News

Pew Charitable Trusts Announces Groundbreaking Research Pairs

Pew Charitable Trusts Announces Groundbreaking Research Pairs

Exciting New Research Collaborations at Pew

The Pew Charitable Trusts has recently revealed its latest cohort of researchers under the prestigious Innovation Fund. This initiative aims to foster interdisciplinary collaboration among scientists dedicated to expanding the boundaries of biomedical research.

Innovative Minds Joining Forces

This year, the program welcomes 14 distinguished scientists, all of whom have made significant contributions to the fields of neuroscience, immunology, and cancer biology. Their collective expertise is set to pave the way for groundbreaking investigations into human health and disease.

Donna Frisby-Greenwood, a spokesperson for Pew, expressed enthusiasm for the newly selected researchers, emphasizing that collaborative efforts are often the source of the most impactful scientific advancements. The Innovation Fund aims to harness this collaborative spirit to unlock further scientific breakthroughs.

The Evolution of the Innovation Fund

The Innovation Fund, initiated in 2017, represents a continued commitment by Pew to support biomedical scientists. Funded by the Kathryn W. Davis Peace by Pieces Fund, this program seeks to stimulate creative partnerships among Pew alumni who hold assistant professor positions or higher. With additional backing from the Chan Zuckerberg Initiative this year, the fund is more than equipped to support diverse and ambitious research projects.

Highlighting the Research Teams

The newly formed teams are tackling a wide array of research inquiries:

  • Carlos Carmona-Fontaine, Ph.D., New York University, and Piro Lito, M.D., Ph.D., Memorial Sloan Kettering Cancer Center, will explore how cell cooperation impacts cancer therapy resistance.
  • Juan Du, Ph.D., Northwestern University, and Marco Gallio, Ph.D., Northwestern University, will investigate changes in a fruit fly ion channel originally used for taste that evolved into a heat sensor.
  • Andrew L. Goodman, Ph.D., Yale School of Medicine, and Ivaylo I. Ivanov, Ph.D., Columbia University, plan to research the interaction between gut microbes and medical drugs to activate antimicrobial peptides.
  • Eduardo Perozo, Ph.D., University of Chicago, and Juan-Pablo Castillo, Ph.D., Centro Interdisciplinario de Neurociencia de Valparaíso, will examine molecular principles behind mechanotransduction, converting mechanical stimuli to electrical signals for brain decoding.
  • Richard L. Possemato, Ph.D., New York University School of Medicine, and Michelle Krogsgaard, Ph.D., New York University School of Medicine, will study how metabolic limitations affect T cell function in hostile tumor environments.
  • Michael J. Rust, Ph.D., University of Chicago, and Suckjoon Jun, Ph.D., University of California San Diego, will research cyanobacteria's growth regulation and resource allocation in varying environments.
  • John Tuthill, Ph.D., University of Washington, and Sebastian Brauchi, Ph.D., Universidad Austral de Chile, will delve into how certain snow flies adapt to frigid temperatures.

The Role of Pew in Advancing Science

Founded in 1948, The Pew Charitable Trusts has been dedicated to enhancing public policy, informing the community, and progressing scientific discovery. By bridging interdisciplinary inquiries, Pew is at the forefront of addressing pressing global challenges through innovative research. The organization's commitment to fostering partnerships among scientists highlights its vision for a healthier future.

For any inquiries, Erin Davis can be reached at 202-540-6677.

Frequently Asked Questions

What is the purpose of the Pew Innovation Fund?

The Pew Innovation Fund aims to foster interdisciplinary research collaborations among alumni of Pew's biomedical programs to advance scientific knowledge in health and disease.

Who are the researchers involved in the 2025 class?

The 2025 class includes 14 recognized scientists from various prestigious institutions, collaborating on projects related to cancer biology, immunology, and more.

How can the public benefit from this research?

The findings from these collaborative projects have the potential to drive significant improvements in understanding diseases and informing public health policy.

What historical significance does Pew have in biomedical research?

Pew has a rich history of supporting scientific endeavors since 1948, becoming a leading organization for funding and promoting innovative biomedical research.

How is Pew supporting these collaborative efforts?

Pew provides funding through the Innovation Fund and collaborates with partners like the Chan Zuckerberg Initiative to enhance research capabilities and impact.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

AB Token Launches on BingX with Exciting Reward Programs

Updated Category News Views 159

AB Token Launches on BingX AB DAO is thrilled to announce that AB Token is officially live on BingX, marking a significant milestone in the quest for enhanced global trading accessibility. This launch is designed to facilitate the adoption of AB within the Web3 ecosystem, enabling users worldwide to engage more effectively in trading activities. Deposit & Trade for...

Continue Reading
Exploring Fast Food Alternatives When Chick-fil-A Closes

Updated Category News Views 352

Chick-fil-A's Sunday Closure Impact Chick-fil-A's unique policy of shutting down every Sunday stems from its founder's commitment to his Christian beliefs. This decision, while beneficial for the company’s brand image, creates a noticeable gap in the fast-food market on what is typically a busy day. As one of the leading chicken chains, its absence is felt, opening...

Continue Reading
Bluevale Capital Leads Transformative Housing Initiative in Calgary

Updated Category News Views 200

Transforming Office Spaces into Homes: Bluevale Capital's Latest Project Bluevale Capital continues to lead innovative approaches in urban development. Recently awarded $8.3 million through Calgary's Downtown Development Incentive Program, the company is set to transform an underutilized office tower into much-needed rental homes. This initiative creates 128 new housing...

Continue Reading
NetWitness Celebrates Platform Innovations and Analyst Recognition

Updated Category News Views 101

NetWitness Introduces Exciting Platform Innovations NetWitness, a trusted provider of threat detection technology and incident response services, is making headlines with the release of its latest product platform version. This anticipated launch showcases significant advancements that enhance operational capabilities in threat detection and incident handling. Alongside...

Continue Reading
Optinose Sets Date for Q4 and Full Year Financial Review

Updated Category News Views 105

Optinose Targets Financial Results for Fourth Quarter and Year-End Optinose (NASDAQ:OPTN), a specialty pharmaceutical company focused on ear, nose, and throat (ENT) and allergy care, has exciting news regarding its upcoming financial report. The company has scheduled to unveil its financial results and corporate updates for both the fourth quarter and the entirety of...

Continue Reading